As this concentration also caused almost total inhibition of the PARP activity in medulloblastoma cells, we used a concentration of 0.4 μM AG-014699 to study the chemosensitisation of temozolomide, enabling comparison with previous data. The gene discussed is PARP1; the disease is medulloblastoma.